BI
GBIO

BVF Inc’s Generation Bio GBIO Stock Holding History

BVF Inc’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,290
Closed -$404K – 75
2022
Q4 		$404K Sell
10,290
-25,892
-72% -$1.36M 0.02% 76
2022
Q3 		$1.92M Sell
36,182
-119,421
-77% -$7.47M 0.08% 68
2022
Q2 		$10.3M Sell
155,603
-124,692
-44% -$8.15M 0.5% 51
2022
Q1 		$20.6M Buy
280,295
+261,390
+1,383% +$15.1M 0.82% 35
2021
Q4 		$1.34M Buy
+18,905
New +$3.3M 0.05% 80

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc's GBIO Position: Q1 2023 in Review

BVF Inc sold out of Generation Bio (GBIO) in Q1 2023, closing a stake of 10,290 shares — an estimated $404K sold.

BVF Inc first reported a position in GBIO in Q4 2021 and held it in 5 quarters. The position peaked at $20.6M in Q1 2022. 83 funds tracked by Wall St. Rank hold GBIO as of Q1 2023.

  • BVF Inc reported no remaining Generation Bio position as of Q1 2023 after selling out during the quarter.
  • BVF Inc sold 10,290 Generation Bio shares in Q1 2023, an estimated $404K.
  • BVF Inc first reported a position in Generation Bio in Q4 2021 and held it in 5 quarters.
  • BVF Inc's Generation Bio position peaked at $20.6M in Q1 2022.
  • 83 funds tracked by Wall St. Rank held Generation Bio as of Q1 2023.

Based on BVF Inc's 13F filing for Q1 2023, filed 15 May 2023.